TY - GEN
AU - Bajorin, Dean F.
AU - Sharma, Padmanee
AU - Lerner, Seth P.
AU - Sims, Robert Brownell
AU - Sanders, Amanda
AU - DeVries, Todd
AU - Sheikh, Nadeem A.
AU - Gomella, Leonard G.
TI - Preliminary safety, product parameters, and immune response assessments from a phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy (ACI), in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence.
PB - American Society of Clinical Oncology (ASCO)
SN - 1527-7755
SN - 0732-183X
KW - Cancer Research
KW - Oncology
PY - 2013
UR - http://slubdd.de/katalog?TN_libero_mab2
ER -
Download citation